Published Medical Diagnostic For Breast Cancer Since breast cancer is a heterogeneous disease composed of various molecular subtypes, the need for biomarkers that permits prognostication across subtypes is advantageous. By University of California, San Diego
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
